Hepatic infarction in a pregnant woman with antiphospholipid syndrome and early pre-eclampsia: A case report

Lampros Ntovas , Athanasios Moles , Nektaria Papadatou , Eugenia Kourakou , Kiriakos Mazis , Leonidas Grigorakos

Case Reports in Internal Medicine ›› 2020, Vol. 7 ›› Issue (2) : 18 -21.

PDF (230KB)
Case Reports in Internal Medicine ›› 2020, Vol. 7 ›› Issue (2) :18 -21. DOI: 10.5430/crim.v7n2p18
CASE REPORTS
research-article

Hepatic infarction in a pregnant woman with antiphospholipid syndrome and early pre-eclampsia: A case report

Author information +
History +
PDF (230KB)

Abstract

The aim of the present case report is to stress out the occurrence of hepatic infraction in pregnant women with antiphospholipid syndrome (APS) and the critical role magnetic resonance imaging (MRI) plays for the early diagnosis of rare complications of the disease. Here we report the case of a preeclamptic pregnant woman with APS in her 17th week of gestation, who experienced severe epigastric pain, followed by multiple episodes of vomiting and an episode of soft stools. Patient was submitted to MRI examination of the upper abdomen, where findings suggested hepatic infarction with subsequent deterioration of her general status. Therefore, she underwent termination of gestation. We conclude that pregnancy is a deteriorating factor of the disease and patient should be closely monitored, evaluated of any suspicious symptom or sign.

Keywords

Antiphospholipid syndrome / Hepatic infarction / MRI / Pregnancy management

Cite this article

Download citation ▾
Lampros Ntovas, Athanasios Moles, Nektaria Papadatou, Eugenia Kourakou, Kiriakos Mazis, Leonidas Grigorakos. Hepatic infarction in a pregnant woman with antiphospholipid syndrome and early pre-eclampsia: A case report. Case Reports in Internal Medicine, 2020, 7(2): 18-21 DOI:10.5430/crim.v7n2p18

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Vitoratos N, Avarantinos L. Antiphospholipid syndrome and pregnancy. Perigenetic Medicine and Neonatology. 2011; 6(2): 35-43 (in Greek).

[2]

Paulzner R, Dulitzky M, Carp H, et al. Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome. Journal of Thrombosis and Haemostasis. 2003; 1: 1758-1763. PMid:12911590. https://doi.org/10.1046/j.1538-7836.2003.00253.x

[3]

Lazzaroni MG, Fredi M, Andreoli L, et al. Triple Antiphospholipid (aPL) Antibodies Positivity is Associated with Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies. Front Immunol. 2019 Aug 14; 10: 1948. PMid:31475009. https://doi.org/10.3389/fimmu.2019.01948

[4]

Guo Q, Yang Z, Guo J, et al. Hepatic infarction induced by HELLP syndrome: a case report and review of the literature. BMC Pregnancy and Childbirth. 2018; 18: 191. PMid:29848304. https://doi.org/10.1186/s12884-018-1799-9

[5]

Rohan W, Pierangeli S. Pathophysiology of the antiphospholipid antibody syndrome. Auto Immun Highlights. 2011 Nov; 2(2): 35-52. PMid:26000118. https://doi.org/10.1007/s13317-011-0017-9

[6]

Marchetti T, de Moerloose P, Gris JC. Antiphospholipid antibodies and the risk of severe and non-severe pre-eclampsia: the NOHA casecontrol study. J Thromb Haemost. 2016; 14: 675-84. PMid:26782635. https://doi.org/10.1111/jth.13257

[7]

Kim JH, Yee C, Kuk JY, et al. Hepatic infarction in the pregnant woman with antiphospholipid syndrome and triple antibody positivity: A case report focusing on catastrophic antiphospholipid syndrome. Obstet Gynecol Sci. 2016; 59(5): 397-402. PMid:27668204. https://doi.org/10.5468/ogs.2016.59.5.397

[8]

Navarro CD, Del Carmen Castillo-Hernandez M, Majluf-Cruz K, et al. Impact of Classical Risk Factors for Arterial or Venous Thrombosis in Patients with Antiphospholipid Syndrome. Clin Appl Thromb Hemost. 2018 Jul; 24(5):834-840. PMid:28884609. https://doi.org/10.1177/1076029617727859

[9]

Di PF, Valenti O, Hyseni E, et al. Antiphospholipid Syndrome during pregnancy: the state of the art. J Prenat Med. 2011 Apr; 5(2):41-53.

[10]

Gomez-Puerta JA, Cervera R, Espinosa G, et al. Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases. Ann Rheum Dis. 2007; 66: 740-746. PMid:17223653. https://doi.org/10.1136/ard.2006.061671

[11]

Galli M. Treatment of the antiphospholipid syndrome. Auto Immun Highlights. 2013 Dec 22; 5(1): 1-7. PMid:26000150. https://doi.org/10.1007/s13317-013-0056-5

[12]

Troja A, Abdou A, Rapp C, et al. Management of Spontaneous Hepatic Rupture on Top of HELLP Syndrome: Case Report and Review of the Literature. Viszeralmedizin. 2015 Jun; 31(3): 205-8. PMid:26468317. https://doi.org/10.1159/000376601

[13]

Ray JG, Vermeulen MJ, Bharatha A, et al. Association Between MRI Exposure During Pregnancy and Fetal and Childhood Outcomes. JAMA. 2016; 316(9): 952-961. PMid:27599330. https://doi.org/10.1001/jama.2016.12126

[14]

UCSF Department of Radiology and Biomedical Imaging, CT and MR Pregnancy Guidelines. Available from: https://radiology.ucsf.edu/patient-care/patient-safety/ct-mri-pregnancy#accordion-pregnancy-and-mri-inpatients

PDF (230KB)

97

Accesses

0

Citation

Detail

Sections
Recommended

/